Literature DB >> 24251149

Cerebral venous sinus thrombosis with autoimmune thyroiditis.

Sameer Aggarwal1, Nityanand Sharma.   

Abstract

Cerebral Venous Thrombosis (CVT) is a multifactorial condition which is described as idiopathic in 12.5% of patients. Hyperthyroidism has been associated with CVT in many case reports, and increased levels of factor VIII and von Willebrand factor (vWF) have been proposed as the possible link in this association, but only few rare case reports have described an association of hypothyroidism with CVT. We report here a case of autoimmune thyroiditis presenting with CVT.

Entities:  

Keywords:  Cerebral vein thrombosis; Hashimoto's thyroiditis; hypothyroidism

Year:  2013        PMID: 24251149      PMCID: PMC3830295          DOI: 10.4103/2230-8210.119563

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


INTRODUCTION

Cerebral venous thrombosis (CVT) is idiopathic in around 12.5% of patients.[1] Studies have described links between thyroid disorders and thrombophilia. High concentrations of factor VIII and von Willebrand factor (vWF) contribute to a hypercoagulable state in hyperthyroidism. Lower vWF concentrations in hypothyroidism may protect against venous thrombosis.[2]. Studies have suggested hypercoagulable state in hypothyroidism.[3] Rare case reports have described association of CVT with autoimmune hypothyroidism.[4] We report here a case of Hashimoto thyroiditis with hypothyroidism who presented with CVT.

CASE PRESENTATION

45-year-old female presented in emergency with complaints of headache since 1 month, vomiting since 1 day, and weakness with numbness and tingling in right half of body since 12 h. Her weakness progressed to quadriparesis overnight. She had no history of fever, head injury, seizures. No history of oral contraceptive use and prolonged immobilization. Her menstrual and obstetric history was unremarkable. On examination she was drowsy and disoriented. On neurological examination, reflexes were present and muscle tone was normal but power was 1/5 on right side and 3/5 in left half of body. Fundoscopy showed papilledema. Normal hemogram and renal and liver function tests. Thyroid function tests were suggestive of subclinical hypothroidism T3 - 0.94 ng/ml, T4 - 8.36 μg/dl, TSH - 13.92 mIU/ml. TPO antibodies were elevated (>1,300 IU/ml). Thrombophilia profile including prothrombin time index/international normalized ratio, serum homocysteine (5.6 mol/l), ANA, lupus anticoagulant, IgM and IgG cardiolipin antibodies, and APLA antibodies were negative. USG of thyroid showed bilateral bulky lobes with altered echotexture s/o thyroiditis. FNAC of thyroid nodule showed lymphocytic infiltration consistent with a diagnosis of Hashimoto thyroiditis. CT head showed hyperdensity in the region of superior sagittal sinus. MRI brain showed loss of flow void of superior sagittal and left transverse sinuses with altered signal appearing hyperintense on T1W and fluid-attenuated inversion recovery (FLAIR) images suggesting thrombosis. She was put on heparin and warfarin. Her headache improved after 4 days of treatment and patient was discharged after 7 days with no residual neurological deficit.

DISCUSSION

Both hyperthyroidism and hypothyroidism have been associated with CVT. Hypothyroidism favors a procoagulant by decreasing fibrinolysis (high levels of alfa2-antiplasmin and plasminogen activator inhibitor-1),[5] inducing hyperhomocysteinemia,[6] and high C-reactive protein (CRP).[7] Decreased fibrinolytic capacity,[8] high CRP levels,[9] and coagulation factors abnormalities can occur even in subclinical hypothyroidism.[3] Elevated plasma thrombin-activatable fibrinolysis inhibitor levels were observed in patients with mild and overt hypothyroidism, and levothyroxine treatment was effective in reducing these levels.[10] Hypothyroidism also contributes to endothelial injury and slow venous flow. Endothelial dysfunction was found in the microvasculature of patients with overt and subclinical hypothyroidism.[9] Chronic low-grade inflammation and impaired nitric oxide availability in the endothelium have been demonstrated in Hypothyroidsm.[11] There is also evidence of increased prevalence of antiendothelial cell antibodies in hypothyroidism.[12] This case emphasizes the need for thyroid evaluation in all patients with CVT and other venous thromboembolic event even in the absence of clinical signs of hypothyroidism.
  12 in total

1.  Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.

Authors:  R Chadarevian; E Bruckert; L Leenhardt; P Giral; A Ankri; G Turpin
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Global fibrinolytic capacity in patients with subclinical hypothyroidism.

Authors:  Sibel Guldiken; Muzaffer Demir; Burhan Turgut; Betul Ugur Altun; Ender Arikan; Mujdat Kara
Journal:  Endocr J       Date:  2005-06       Impact factor: 2.349

3.  Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis.

Authors:  Stefano Taddei; Nadia Caraccio; Agostino Virdis; Angela Dardano; Daniele Versari; Lorenzo Ghiadoni; Ele Ferrannini; Antonio Salvetti; Fabio Monzani
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

4.  Deep vein thrombosis and euvolemic hyponatremia in a hypothyroid patient.

Authors:  V Umadevi; J Rajesh; S Suresh Saravana Kumar; R Mohammed Shakir; C Vijayashankar; C Vijay Prasad
Journal:  J Assoc Physicians India       Date:  2011-11

5.  Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey.

Authors:  M S Morris; A G Bostom; P F Jacques; J Selhub; I H Rosenberg
Journal:  Atherosclerosis       Date:  2001-03       Impact factor: 5.162

6.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

7.  The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.

Authors:  Omer Ozcan; Erdinc Cakir; Halil Yaman; Emin Ozgur Akgul; Kivilcim Erturk; Zeynel Beyhan; Cumhur Bilgi; Mehmet Kemal Erbil
Journal:  Clin Endocrinol (Oxf)       Date:  2005-08       Impact factor: 3.478

8.  Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial.

Authors:  Mirjam Christ-Crain; Christian Meier; Merih Guglielmetti; Peter R Huber; Walter Riesen; Jean Jacques Staub; Beat Müller
Journal:  Atherosclerosis       Date:  2003-02       Impact factor: 5.162

9.  Hypothyroidism and anti-endothelial cell antibodies.

Authors:  A G Wangel; S Kontiainen; L Melamies; T Weber
Journal:  APMIS       Date:  1993-01       Impact factor: 3.205

Review 10.  Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review.

Authors:  A Squizzato; E Romualdi; H R Büller; V E A Gerdes
Journal:  J Clin Endocrinol Metab       Date:  2007-04-17       Impact factor: 5.958

View more
  3 in total

Review 1.  Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-03-09

2.  Progressive Ischemic Stroke due to Thyroid Storm-Associated Cerebral Venous Thrombosis.

Authors:  Natsumi Tanabe; Eiji Hiraoka; Masataka Hoshino; Gautam A Deshpande; Kana Sawada; Yasuhiro Norisue; Jumpei Tsukuda; Toshihiko Suzuki
Journal:  Am J Case Rep       Date:  2017-02-23

3.  A Rare Case of Coronavirus Disease 2019 Vaccine-Associated Cerebral Venous Sinus Thrombosis Treated with Mechanical Thrombectomy.

Authors:  Hitesh Gurjar; Manjeet Dhallu; Dmitry Lvovsky; Samiyah Sadullah; Sridhar Chilimuri
Journal:  Am J Case Rep       Date:  2022-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.